This publication is unavailable to your account. If you have more privileged account please try to use it or contact with the institution connected to this digital library.
Ząbczyk, Michał
2016
Praca doktorska
Atrial fibrillation (AF) increases the risk of thromboembolism that is reduced by vitamin K antagonists (VKAs). Prothrombotic fibrin clot phenotype might be arisk factor for thromboembolic complications. Fibrin clot properties in patients taking VKAs have not been investigated yet. We evaluated an automated method for fibrin clot permeability (Ks) assessment, tested whether long-term treatment with VKAs affects the structure of fibrin network, and investigated changes in plasma fibrin clot phenotype at the onset of oral anticoagulation. We showed that 10 pM TF as a coagulation trigger may reflect the in vivo process from initiation of the coagulation cascade to fibrin formation in AF patients taking VKAs. Finally, we demonstrated that plasma fibrin clot properties in AF patients are favourably modified as early as after 3 days of VKA administration, which might contribute to anticoagulant and antithrombotic effectiveness.
Kraków
2 - studia doktoranckie
choroby układu krążenia
Wydział Lekarski
Undas, Anetta
2015
oai:dl.cm-uj.krakow.pl:4058
ZB-124213
pol; eng
tylko w bibliotece
Jun 26, 2023
Apr 11, 2016
35
0
http://dl.cm-uj.krakow.pl:8080/publication/4058
RDF
OAI-PMH
Rewiuk, Krzysztof
Kiełbasa, Grzegorz Stanisław
Lenart-Migdalska, Aleksandra
Kocowska, Maryla
Myrdko, Tomasz
Litwinowicz, Radosław
Burysz, Marian
Citation style: chicago-author-date iso690-author-date
This page uses 'cookies'. More information I understand